| Bioactivity | S-Gem is a TrxR-dependent prodrug of Gemcitabine (HY-17026) and selectively activated by TrxR. S-Gem shows less cytotoxicity compared to Gemcitabine[1]. |
| Name | S-Gem |
| CAS | 2169925-98-6 |
| Formula | C13H15F2N3O6S2 |
| Molar Mass | 411.40 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Li X, et, al. Combination of chemotherapy and oxidative stress to enhance cancer cell apoptosis. Chem Sci. 2020 Feb 25;11(12):3215-3222. |
S-Gem
CAS: 2169925-98-6 F: C13H15F2N3O6S2 W: 411.40
S-Gem is a TrxR-dependent prodrug of Gemcitabine (HY-17026) and selectively activated by TrxR. S-Gem shows less cytotoxi
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.